Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease

Abstract

A single unilateral intramuscular administration of AdVEGF121 was not associated with improved exercise performance or quality of life in this study. This study does not support local delivery of single-dose VEGF121 as a treatment strategy in patients with unilateral PAD.